Hepatology 46 , 18441852 (2007)
HIPAA Compliance Is the Starting Point, Not the Feature Every healthcare platform claims HIPAA compliance
Synthetic small molecule SIRT1 activators Compared with natural products, synthetic SIRT1 activators offer several advantages, including defined molecular structures, high target selectivity, and stable pharmacokinetic profiles, making them a promising direction for the clinical application of SIRT1-targeted therapies
Intriguingly, XIST can also enhance HIF-1 expression via the XIST/ miR-93 /HIF-1 pathway, thereby promoting glycolysis in TC [203]
Park CH, Abramson ZR, Taba M Jr, et al
3.1 Inhibition of Glutaminolysis by GLS Inhibitors The most straightforward approach for targeting glutaminolysis is the inhibition of GLS, which catalyzes the hydrolysis of glutamine to glutamate